Biosimilars in Oncology: An Interview With Eric Zack, DNP, RN, ACNP-BC, AOCN®, BMTCN®
Devi Seal
ONS Congress
Biosimilars—a biologic that is "similar" to another biologic drug that is already FDA approved—are becoming more common to prescribe to patients with various conditions. It is crucial for health care providers to keep abreast of the current information regarding biosimilars. To help educate oncology nurses on this emerging field, Eric Zack, DNP, RN...
Optimizing Oral Chemotherapy Patient Education With Robin Esposito, RN, BSN, OCN®
Sarah Williams, MAT
Practice Patterns
​Because oral chemotherapy agents are administered by the patient at home without direct supervision from a nurse, patients often call with questions and concerns about their medications. Seeking to prevent lost time and patient confusion, Robin Esposito, RN, BSN, OCN®, undertook a project aimed at improving communication and education regarding or...
I-SNAP: Immunotherapy Standardized Nursing Assessment Protocol With Keri Mahoney, JD, RN, CPHRM
Devi Seal
Practice Patterns
With the rapidly increasing use of immunotherapy in the treatment of some cancers, oncology nurses need to be comfortable and knowledgeable in administering immunotherapeutic treatments and assessing patients for immune-related adverse events. In this interview with i3 Health, Keri Mahoney, JD, RN, CPHRM, discusses her immunotherapy educational int...
Preparing Nurses to Manage CAR T-Cell Therapy Adverse Events With Lindsey Bashaw, RN
Amanda Thompson
Practice Patterns
Chimeric antigen receptor (CAR) T-cell therapy is a new form of immunotherapy in which a patient's own T cells are collected and genetically altered to target cancer cells. Although CAR T-cell therapy has shown encouraging clinical trial results in patients with acute lymphoblastic leukemia and B-cell lymphomas, they are associated with severe adve...
“Getting Their Attention: Streamlining Patient Education” With Margaret Highley, MSN, RN, OCN®, and Rebecca Grimmett, RN, OCN®
Sarah Williams, MAT
Practice Patterns
Patient education regarding the purpose and side effects of medications can be important to ensuring adherence and optimizing patient outcomes. However, it can be difficult for patients to absorb this information while experiencing an episode of acute illness, especially given the anxiety that can accompany a frightening diagnosis such as cancer. M...
Raising Awareness of Lung Cancer Screening Through Social Media: An Interview With Aimee Strong, MSN, AGACNP-BC
Sarah Williams, MAT
Practice Patterns
​Lung cancer screening using low-dose computed tomography (CT) has been endorsed by the United States Preventive Services Task Force and is covered by most insurances, yet this service is still underutilized, and some individuals at high risk for lung cancer may not know that it exists. Aimee Strong, MSN, AGACNP-BC, investigated whether social medi...
Urology/Oncology Preferences: Continuing Medical Education
Emily Levitch
Practice Patterns
In order to accurately recognize the continuing medical education (CME) needs and preferences of urology/oncology health care providers, i3 Health administered a survey to participants at the 66th Society of Government Service Urologists Kimbrough Urological Seminar. The results obtained from the survey will be used by i3 Health in the planning and...
Hematology/Oncology Fellow Preferences: Continuing Medical Education (CME)
Devi Seal
Practice Patterns
In order to identify the continuing medical education needs and preferences of hematology/oncology fellows, i3 Health administered a survey to participants at several live CME-certified visiting faculty meetings. i3 Health intends to use the results gathered from the survey in the planning and implementation of CME-certified activities. Of the 54 p...
Management of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors With Sara Tinsley, PhD, ARNP, AOCN
Devi Seal
Leukemia
Chronic myeloid leukemia (CML) accounts for 15% of all adult leukemias and is characterized by heterogenous clinical manifestations. In recent years outcomes for patients with CML have greatly improved, in part due to the advent of tyrosine kinase inhibitor (TKI) therapy. At the Oncology Nursing Society 43rd Annual Congress in Washington, DC, i3 He...
Exploring the Effects of Chemo Brain in Breast Cancer Patients With Patricia A. Gibbons, PhD, RN, AOCN
Devi Seal
ONS Congress
Many patients with cancer who receive systemic therapy experience cancer treatment-related cognitive impairment, commonly referred to as "chemo brain." Chemo brain is characterized by the inability to remember certain things and having trouble finishing tasks or learning new skills. For most patients, these effects are short-term; however, other pa...
Demoralization and Suicidal Ideation Among Cancer Patients With Nancy Gilbert, MSN, RN, OCN
Devi Seal
Practice Patterns
The incidence of suicide among patients with cancer in the United States is twice that of the general population. Studies demonstrate that demoralization, defined as lowered morale and perceived incapacity to cope, is strongly and independently related to suicidal ideation among cancer patients. Nancy Gilbert, MSN, RN, OCN and colleagues performed ...
Immunotherapy in Chronic Lymphocytic Leukemia With Adrianne Janicik, BSN, RN, OCN
Devi Seal
ONS Congress
Chronic lymphocytic leukemia (CLL) has a heterogenous disease course, and questions remain regarding when to initiate therapy, the application of prognostic markers, and the optimal regimens and sequences of agents for individual patients. At the Oncology Nursing Society 43rd Annual Congress in Washington, DC, i3 Health spoke with Adrianne Janicik, BSN, RN, OCN®, from Vanderbilt University Medical Center, about advances in immunotherapy for CLL and the importance of ensuring therapy adherence.

Copyright © 2022 Oncology Data Advisor. All rights reserved.